ReviewF1000Research2020

New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer's disease: focus on brexpiprazole and pimavanserin.

Filippo Caraci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.